China's Avionics Dark Horse Yunji Avionics Closes Three Funding Rounds in Eight Months

Chinese avionics startup Yunji Avionics has completed Pre-A and Pre-A+ funding rounds totaling tens of millions of yuan in rapid succession, bringing its fundraising tally to three rounds in under eight months. Investors include Haihe Industrial Fund, Yizhuang Xincheng Industrial, Houtian Capital, Chengdu, and Zhongli Fund, with proceeds earmarked for R&D, airworthiness certification, and production expansion. Founded less than four years ago, Yunji Avionics is pursuing fully indigenous integrated avionics systems — the electronic "brains" of aircraft — in a market long dominated by Western giants Honeywell, Collins Aerospace, Thales, and GE, which collectively control over 80% of global market share. With China's push for aviation supply chain autonomy and the rise of domestic commercial aircraft and eVTOL platforms, the timing is strategic. Yunji has developed three product series — YJ-500E, YJ-1000E, and YJ-3000E — covering light sports aircraft, normal category aircraft, and mid-size (19-seat and below) aviation platforms, compatible with fixed-wing, helicopter, and eVTOL configurations. The YJ-500E, positioned for mid-range integrated avionics, has completed onboard verification on models including the RX1E-A, AC311A, and WZ-11, and is expected to receive its first airworthiness certification in the second half of this year. Key technical differentiators include 90% domestically sourced components, reducing overall costs to 50–70% of international competitors, and power consumption reduced to just 30% of comparable products — a critical advantage given the limited battery capacity of electric aircraft. The company selected an MCU-centric computing architecture over the industry-standard CPU+GPU approach, achieving a 10-fold power reduction through stacked chip packaging. Founder Li Bei emphasizes a long-term strategy of at least a decade of sustained R&D investment, targeting domestic military and state-owned aviation programs first before expanding into the broader commercial market. Revenue is projected at approximately RMB 20 million this year as initial batch deliveries commence.